Laser company for medical applications - Modulight
Personalized medicine and better life
We’re helping people with their novel ideas. We have experience in productization, manufacturing subassemblies in regular production, as well as working to support end-of-life as an equally important phase in the life cycle of a medical product.
Products in spotlight:
ML6710i
ML6710i is a medical laser device for ophthalmology. It’s specifically designed for retinal PDT treatments. The laser is controlled intuitively from iPad app, and it’s very easy to use. Most popular option is to get the laser with the ophthalmic treatment station, allowing always a dedicated PDT laser station ready for patients.
ML7710
ML7710 is the most versatile multichannel & multi-indication laser in the world. The treatment flow has been optimized and it can be further customized to specific needs. ML7710 supports all known photosensitizers. As the only true medical laser platform, it also boasts unmatched security for the investment.
ML8500
ML8500 is a fully automated biomedical illumination system for well plate and petri dish samples. ML8500 has up to six built-in lasers. Cloud-based composition of illumination programs can be done remotely which enables effective research work. ML8500 keeps sample plates within a specified temperature and CO2 range.
Upcoming Events
Latest news and articles
Cheng-Yu Lai et al. at Florida International University explores a solution for antibiotic-free wound healing. A photothermally controllable hydrogel was illuminated by NIR light from ML6600 laser, causing complete eradication of bacteria.
Gokalp et al. from University of Massachusetts and Tufts University constructed an innovative liquid metal nanoparticle platform, which has tumor cell targeting and enhanced encapsulation of verteporfin. Charactierization in vitro with the help of ML6600 laser showed effective in vitro phototoxicity.
Published in: Cancer Science Authors: Hiroshi Yamamoto, Aki Furusawa, Hiroshi Fukushima, Seiichiro Takao, Motofumi Suzuki, Makoto Kano, Miyu Kano, Shuhei Okuyama, Ko Kitamura, Peter L. Choyke, Hisataka Kobayashi
Published in: SPIE OPTO 2025 Authors: Luukas Kuusela, Timo Aho, Riina Ulkuniemi, Mika Mähönen, Jussi Hämelahti, Andreas Schramm, Soile Talmila, Jarkko Liimatainen, Pekko Sipilä, Petteri Uusimaa
Published in: SPIE BIOS 2025 Authors: Anna Essauolva, Sergei Kuehn, Visa Kaivosoja, Andrei Fedotov, Petteri Uusimaa
Published in: SPIE OPTO 2025 Authors: Luukas Kuusela, Timo Aho, Riina Ulkuniemi, Mika Mähönen, Jussi Hämelahti, Andreas Schramm, Soile Talmila, Jarkko Liimatainen, Pekko Sipilä, Petteri Uusimaa
Published in: SPIE OPTO 2025 Authors: R. Ulkuniemi, A. Schramm, S. Talmila, M. Mähönen, L. Kuusela, T. Aho, J. Hämelahti, V. Vilokkinen, P. Sipilä, P. Uusimaa
Coleman et al. / MSKCC developed a vascular-targeted therapy for bladder cancer. Padeliporfin is illuminated with the Modulight’s ML7710 laser, resulting in selective ablation of bladder tumors, without harming the healthy bladder tissue.
Modulight in social media
Follow us: modulight.corp modulight.inc modulight modulight.inc modulight